Page last updated: 2024-08-16

risperidone and neuropeptide y

risperidone has been researched along with neuropeptide y in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Gruber, SH; Mathé, AA1
de Castella, AR; Fitzgerald, PB; Kulkarni, J; Morris, MJ; Scaffidi, A1
Gruber, SH; Mathé, AA; Nomikos, GG1
Egerod, KL; Holst, B; Husum, H; Mellerup, E; Secher, A1
Ak, M; Kursungoz, C; Sutcigil, L; Yanik, T1
Ak, M; Kursungoz, C; Yanik, T1
Huang, XF; Li, LY; Lin, S; Shi, YC; Song, ZY; Sun, WW; Yang, HQ1
Huang, XF; Lin, S; Shi, YC; Wan, XQ; Wang, L; Yang, HQ; Zeng, F; Zhang, ZH1

Trials

1 trial(s) available for risperidone and neuropeptide y

ArticleYear
The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain.
    Human psychopharmacology, 2003, Volume: 18, Issue:7

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Gonadal Steroid Hormones; Humans; Leptin; Middle Aged; Neuropeptide Y; Olanzapine; Pirenzepine; Radioimmunoassay; Risperidone; Schizophrenia; Time Factors; Weight Gain

2003

Other Studies

7 other study(ies) available for risperidone and neuropeptide y

ArticleYear
Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum.
    Journal of neuroscience research, 2000, Aug-15, Volume: 61, Issue:4

    Topics: Animals; Antipsychotic Agents; Basal Ganglia; Dextroamphetamine; Haloperidol; Male; Microdialysis; Neuropeptide Y; Rats; Rats, Wistar; Risperidone; Sympathomimetics

2000
Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2006, Volume: 16, Issue:8

    Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Corpus Striatum; Drug Administration Schedule; Drug Interactions; Extracellular Fluid; Haloperidol; Male; Microdialysis; Neuropeptide Y; Neurotensin; Radioimmunoassay; Rats; Rats, Wistar; Risperidone; Time Factors

2006
Risperidone treatment increases CB1 receptor binding in rat brain.
    Neuroendocrinology, 2010, Volume: 91, Issue:2

    Topics: Adiponectin; Animals; Antipsychotic Agents; Brain; Cyclohexanols; Dopamine Antagonists; Eating; Ghrelin; Male; Motor Activity; Neuropeptide Y; Pro-Opiomelanocortin; Prolactin; Protein Binding; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Receptors, Ghrelin; Risperidone; RNA, Messenger; Tritium; Weight Gain

2010
Weight gain in risperidone therapy: investigation of peripheral hypothalamic neurohormone levels in psychotic patients.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:5

    Topics: alpha-MSH; Antipsychotic Agents; Appetite Regulation; Body Mass Index; Case-Control Studies; Humans; Hypothalamus; Leptin; Male; Nerve Tissue Proteins; Neuropeptide Y; Risperidone; Treatment Outcome; Weight Gain; Young Adult

2013
Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats.
    Brain research, 2015, Jan-30, Volume: 1596

    Topics: Agouti-Related Protein; alpha-MSH; Animals; Antipsychotic Agents; Appetite; Eating; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hypothalamus; Leptin; Male; Nerve Tissue Proteins; Neuropeptide Y; Neuropeptides; Pro-Opiomelanocortin; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Risperidone; Statistics, Nonparametric

2015
The central mechanism of risperidone-induced hyperprolactinemia.
    Progress in neuro-psychopharmacology & biological psychiatry, 2017, 06-02, Volume: 76

    Topics: Animals; Antipsychotic Agents; Arcuate Nucleus of Hypothalamus; Disease Models, Animal; Female; Hyperprolactinemia; Male; Mice, Inbred C57BL; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Risperidone; Tyrosine 3-Monooxygenase

2017
Risperidone stimulates food intake and induces body weight gain via the hypothalamic arcuate nucleus 5-HT2c receptor-NPY pathway.
    CNS neuroscience & therapeutics, 2020, Volume: 26, Issue:5

    Topics: Animals; Arcuate Nucleus of Hypothalamus; Body Weight; Eating; Female; Mice; Mice, Inbred C57BL; Neuropeptide Y; Receptor, Serotonin, 5-HT2C; Risperidone; Serotonin Antagonists; Signal Transduction; Weight Gain

2020